A Pragmatic Approach to Prostate Cancer Screening

JAMA. 2024 May 7;331(17):1448-1450. doi: 10.1001/jama.2024.4089.

Authors

Jeffrey J Tosoian^{1

2}, David F Penson^{1

2}, Arul M Chinnaiyan^{3

4

5

6}

Affiliations

¹ Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
² Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
³ Department of Pathology, University of Michigan, Ann Arbor.
⁴ Department of Urology, University of Michigan, Ann Arbor.
⁵ Michigan Center for Translational Pathology, University of Michigan, Ann Arbor.
⁶ Rogel Cancer Center, University of Michigan, Ann Arbor.

PMID: 38581253
DOI: 10.1001/jama.2024.4089

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aged
Biopsy / adverse effects
Biopsy / methods
Early Detection of Cancer* / adverse effects
Early Detection of Cancer* / methods
Humans
Kallikreins / blood
Magnetic Resonance Imaging
Male
Mass Screening / adverse effects
Mass Screening / methods
Middle Aged
Overdiagnosis / prevention & control
Overtreatment / prevention & control
Predictive Value of Tests
Prostate / diagnostic imaging
Prostate / pathology
Prostate-Specific Antigen* / blood
Prostatic Neoplasms* / blood
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / pathology
Randomized Controlled Trials as Topic
Watchful Waiting

Substances

Kallikreins
Prostate-Specific Antigen